FDA grants accelerated approval to Vera Therapeutics' kidney drug
Go back to FDA grants accelerated approval to Vera Therapeutics' kidney drug| Veramark Technologies, Inc. (NASDAQ: VERA) | Delayed: 35.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.89 | 52 Week High | $1.18 | |||
| Open | $35.89 | 52 Week Low | $0.36 | |||
| Day High | $35.89 | P/E | 598.17 | |||
| Day Low | $35.89 | EPS | $0.06 | |||
| Volume | 6,976 | |||||
